Extremely Low-Frequency Magnetic Field Enhances the Therapeutic Efficacy of Low-Dose Cisplatin in the Treatment of Ehrlich Carcinoma
Figure 2
The level of DNA damage in Ehrlich tumor cells for mice group (A) treated with cisplatin followed by exposure to ELF-MF, mice group (B) treated with cisplatin, mice group (C) treated by exposure to ELF-MF, and mice group (D) the control one assessed by comet assay. Each value represents the mean ± SE (, )
